CoChat
Sign Up
Cited by 6Liver physiology and pathologyLiver Disease and TransplantationMesenchymal stem cell research

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Macrophage cytotherapy on liver cirrhosis

Open access
Ping, Dabing, Peng, Yuan, Hu, Xudong, Liu, Chenghai·2023·Frontiers in Pharmacology
DOI 10.3389/fphar.2023.1265935PMC PMC10757375
Open this paper in CoChat — free accountOpen PDF

Abstract

Macrophages, an essential cell population involved in mediating innate immunity in the host, play a crucial role on the development of hepatic cirrhosis. Extensive studies have highlighted the potential therapeutic benefits of macrophage therapy in treating hepatic cirrhosis. This review aims to provide a comprehensive overview of the various effects and underlying mechanisms associated with macrophage therapy in the context of hepatic cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2023.1265935

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 40

  1. Asrani, 2019, Burden of liver diseases in the world, J. Hepatol., 70, 151, 10.1016/j.jhep.2018.09.014 · DOI · Paper page
  2. Bird, 2013, Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling, Proc. Natl. Acad. Sci. U. S. A., 110, 6542, 10.1073/pnas.1302168110 · DOI · Paper page
  3. Blouin, 1977, Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study, J. Cell Biol., 72, 441, 10.1083/jcb.72.2.441 · DOI
  4. Borst, 2018, Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis, J. Hepatol., 68, 682, 10.1016/j.jhep.2017.11.029 · DOI
  5. Brennan, 2021, Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH), BMJ Open, 11, e053190, 10.1136/bmjopen-2021-053190 · DOI
  6. Dambach, 2002, Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse, Hepatology, 35, 1093, 10.1053/jhep.2002.33162 · DOI · Paper page
  7. Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J. Clin. Invest., 115, 56, 10.1172/JCI22675 · DOI · Paper page
  8. Elchaninov, 2021, Macro- and microtranscriptomic evidence of the monocyte recruitment to regenerating liver after partial hepatectomy in mouse model, Biomed. Pharmacother., 138, 111516, 10.1016/j.biopha.2021.111516 · DOI
  9. Fraser, 2017, Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: a novel cellular therapeutic for liver cirrhosis, Cytotherapy, 19, 1113, 10.1016/j.jcyt.2017.05.009 · DOI
  10. Friedrich-Rust, 2010, Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis, BMC Gastroenterol., 10, 103, 10.1186/1471-230X-10-103 · DOI
  11. Haideri, 2017, Injection of embryonic stem cell derived macrophages ameliorates fibrosis in a murine model of liver injury, NPJ Regen. Med., 2, 14, 10.1038/s41536-017-0017-0 · DOI
  12. Hogaboam, 2000, Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2, Am. J. Pathol., 156, 1245, 10.1016/S0002-9440(10)64995-4 · DOI
  13. Huang, 2014, Adoptive transfer of heme oxygenase-1 (HO-1)-modified macrophages rescues the nuclear factor erythroid 2-related factor (Nrf2) antiinflammatory phenotype in liver ischemia/reperfusion injury, Mol. Med., 20, 448, 10.2119/molmed.2014.00103 · DOI
  14. Ke, 2010, Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury, Mol. Ther., 18, 1019, 10.1038/mt.2009.285 · DOI
  15. Ko, 2019, Hdac1 regulates differentiation of bipotent liver progenitor cells during regeneration via Sox9b and Cdk8, Gastroenterology, 156, 187, 10.1053/j.gastro.2018.09.039 · DOI
  16. Kong, 2012, Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice, Hepatology, 56, 1150, 10.1002/hep.25744 · DOI · Paper page
  17. Li, 2021, Infusion of kupffer cells expanded in vitro ameliorated liver fibrosis in a murine model of liver injury, Cell Transpl., 30, 9636897211004090, 10.1177/09636897211004090 · DOI · Paper page
  18. Liaskou, 2013, Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics, Hepatology, 57, 385, 10.1002/hep.26016 · DOI
  19. Lu, 2020, MSCs contribute to the conversion of Ly6C(high) monocytes into Ly6C(low) subsets under AMI, Stem Cells Int., 2020, 2460158, 10.1155/2020/2460158 · DOI
  20. Ma, 2022, The contribution of hepatic macrophage heterogeneity during liver regeneration after partial hepatectomy in mice, J. Immunol. Res., 2022, 3353250, 10.1155/2022/3353250 · DOI
  21. Merlin, 2016, Kupffer cell transplantation in mice for elucidating monocyte/macrophage biology and for potential in cell or gene therapy, Am. J. Pathol., 186, 539, 10.1016/j.ajpath.2015.11.002 · DOI
  22. Moore, 2015, Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study, Cytotherapy, 17, 1604, 10.1016/j.jcyt.2015.07.016 · DOI
  23. Mossanen, 2016, Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury, Hepatology, 64, 1667, 10.1002/hep.28682 · DOI · Paper page
  24. Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat. Rev. Immunol., 8, 958, 10.1038/nri2448 · DOI · Paper page
  25. Murray, 2014, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, 41, 14, 10.1016/j.immuni.2014.06.008 · DOI · Paper page
  26. Murray, 2011, Protective and pathogenic functions of macrophage subsets, Nat. Rev. Immunol., 11, 723, 10.1038/nri3073 · DOI · Paper page
  27. Ping, 2023, Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe, Chin. Med., 18, 51, 10.1186/s13020-023-00754-4 · DOI
  28. Pu, 2023, Bipotent transitional liver progenitor cells contribute to liver regeneration, Nat. Genet., 55, 651, 10.1038/s41588-023-01335-9 · DOI · Paper page
  29. Ramachandran, 2019, Resolving the fibrotic niche of human liver cirrhosis at single-cell level, Nature, 575, 512, 10.1038/s41586-019-1631-3 · DOI · Paper page
  30. Ramachandran, 2012, Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis, Proc. Natl. Acad. Sci. U. S. A., 109, E3186, 10.1073/pnas.1119964109 · DOI · Paper page
  31. Starkey Lewis, 2020, Alternatively activated macrophages promote resolution of necrosis following acute liver injury, J. Hepatol., 73, 349, 10.1016/j.jhep.2020.02.031 · DOI · Paper page
  32. Sun, 2021, Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1/M2-macrophage infusion on liver recovery after hepatectomy, Cell Death Dis., 12, 324, 10.1038/s41419-021-03616-9 · DOI
  33. Wang, 2020, MicroRNA-98 inhibits hepatic stellate cell activation and attenuates liver fibrosis by regulating HLF expression, Front. Cell Dev. Biol., 8, 513, 10.3389/fcell.2020.00513 · DOI
  34. Xu, 2004, Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats, World J. Gastroenterol., 10, 3621, 10.3748/wjg.v10.i24.3621 · DOI
  35. Yang, 2020, Adoptive transfer of polarized M2c macrophages ameliorates acute rejection in rat liver transplantation, Am. J. Transl. Res., 12, 2614
  36. You, 2013, Role of hepatic resident and infiltrating macrophages in liver repair after acute injury, Biochem. Pharmacol., 86, 836, 10.1016/j.bcp.2013.07.006 · DOI
  37. Zhang, 2017, Human induced pluripotent stem cell-derived macrophages for unraveling human macrophage biology, Arterioscler. Thromb. Vasc. Biol., 37, 2000, 10.1161/ATVBAHA.117.309195 · DOI
  38. Zhao, 2022, ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection, J. Clin. Invest., 132, e150489, 10.1172/JCI150489 · DOI
  39. Zhao, 2021, Injection of CD86(+) macrophages instead of liver partition for the acceleration of liver regeneration after portal vein ligation in rats, Arch. Med. Sci., 17, 843, 10.5114/aoms/133361 · DOI
  40. Zlotnik, 2012, The chemokine superfamily revisited, Immunity, 36, 705, 10.1016/j.immuni.2012.05.008 · DOI

Cited by

Sorted by citations

See all 6

Metadata

Authors
Ping, D., Peng, Y., Hu, X., & Liu, C.
Affiliations
Shanghai University of Traditional Chinese Medicine (CN)
Corresponding author
Liu, Chenghai
ORCID
Venue
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Published
2023-12-15
Volume
14
Pages
1265935-1265935
ISSN
1663-9812 (ISSN-L)
DOI
10.3389/fphar.2023.1265935
PMC
PMC10757375
OpenAlex
W4389792691
Cited by
6
References
8
Citations by year
2026: 2 · 2025: 3 · 2024: 1
FWCI
0.26
Type
journal article
Language
en
Open access
Licence
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
macrophage therapy, liver cirrhosis, macrophages, innate immunity, cell therapy, therapeutic mechanisms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review